What is it about?
A Swedish translation of the patient-reported outcome measure for assessing long-term control of atopic dermatitis, Recap of atopic eczema (RECAP), has not been validated. Cross-cultural translation and multi-centre validation of the translated RECAP questionnaire were therefore performed.
Featured Image
Why is it important?
The Recap of atopic eczema questionnaire is a new longterm outcome measure to evaluate disease control in patients with atopic dermatitis. The Harmonizing Outcome Measures for Eczema initiative has recommended Recap of atopic eczema questionnaire as a core outcome measure to be used in all clinical trials. This validation enables the use of Recap of atopic eczema questionnaire to evaluate and compare long-term atopic dermatitis control in routine healthcare and clinical research in Sweden.
Read the Original
This page is a summary of: Cross-Cultural Validation of the RECAP of Atopic Eczema Questionnaire in a Swedish Population, Acta Dermato Venereologica, June 2024, Acta Dermato-Venereologica,
DOI: 10.2340/actadv.v104.38889.
You can read the full text:
Contributors
The following have contributed to this page